LA PARALYSIE FACIALE PERIPHERIQUE ZOSTERIENNE : PARTICULARITES DIAGNOSTIQUES ET THERAPEUTIQUES A PROPOS DUN CAS

  • Service d Otorhinolaryngologie et de Chirurgie Cervico-Faciale de l Hopital Militaire d Instruction Mohamed V de Rabat.
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Zoster-related peripheral facial paralysis is a late complication of infection with the varicella-zoster virus, secondary to reactivation of this virus, which has been dormant in the sensory ganglion cells of the facial nerve since the initial varicella infection. It accounts for 3 to 12% of peripheral facial paralysis cases, 30% of which are an eruptive, and its treatment is often medical, rarely surgical, and the prognosis is sometimes poor despite early treatment.We report the case of a 23-year-old male patient admitted to the ENT emergency department for right peripheral facial paralysis associated with otalgia and ipsilateral facial rash that had been developing for two days. Treatment was based on an antiviral (acyclovir) combined with corticosteroid therapy (prednisone 1 mg/kg/day for 10 days), an analgesic, local care, and motor physiotherapy. The course of the disease was marked by a regression of the vesicular lesions and a marked improvement in facial paralysis within 3 months.


[Rouihi, R.D.Benariba, M.Kettani, S.Ouraini B.Hemmaoui, M.Zalagh F. Benariba and N.Errami (2025); LA PARALYSIE FACIALE PERIPHERIQUE ZOSTERIENNE : PARTICULARITES DIAGNOSTIQUES ET THERAPEUTIQUES A PROPOS DUN CAS Int. J. of Adv. Res. (Oct). 327-331] (ISSN 2320-5407). www.journalijar.com


Rouihi
Ahmed
Morocco